Definitive Contract 75A50121C00015
Award Date
1/5/21
Potential Completion Date
1/15/21
Potential Value
$4.5M
Awardee
Kaleo, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30331, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Mylan Specialty L.P. was awarded a definitive contract by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to purchase epinephrine auto-injectors for the Strategic National Stockpile. Valued at $8.25 million, this firm fixed price contract will provide funding to procure these medical devices to support the federal government's ongoing COVID-19 response efforts over an 11-day period of performance in Chamblee, Georgia. No subcontractors...
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded Kaleo, Inc., a $30,344,948.00 cost-plus-fixed-fee contract for the development of a novel pralidoxime chloride auto-injector device. This contract supports ASPR's Biomedical Advanced Research and Development Authority (BARDA) program, which focuses on medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $2.2 million firm fixed price definitive contract to Amneal Pharmaceuticals of New York, LLC for the purchase of 20,000 auto injectors to support COVID-19 national interest activities. Performance will occur at Amneal's facility in Chamblee, Georgia over an eight-day period concluding on January 15, 2021. No subcontractors or set aside designations were identified. This...
The U.S. Defense Logistics Agency (DLA) awarded a $2,242.95 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,133,907 units of Epinephrine 0.3 mg auto-injectors. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, valued at $2,570.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4,566,929,072 units of epinephrine 0.3 mg auto-injectors, a critical medical product used for emergency treatment of severe allergic reactions. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
The Defense Logistics Agency awarded a $306,260 delivery order to Amerisourcebergen Drug Corporation for the supply of 4561326053 epinephrine autoinjectors (0.3 mg, 2-pack). As part of its stockpile of medical countermeasures, DLA will receive the autoinjectors from Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 26, 2023 under a firm fixed price contract. No subcontractors or set aside designations were identified. DLA manages the Department of Defense's global supply chain...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide epinephrine 0.3 mg auto-injectors. The $1,710.38 contract has a completion date of December 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Epinephrine 0.3 mg auto-injectors, with a ceiling value of $8,824.38 and a completion date of June 10, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Epinephrine 0.3 mg auto-injectors. The fixed-price delivery order, valued at $5,240.52, was awarded on June 9, 2022, with a completion date of June 10, 2022. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,365,513 units of 0.3 mg epinephrine auto-injectors. The contract has a ceiling value of $19,924.49 and a completion date of August 7, 2024. This order is not set aside for any specific business type. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is associated with...